Bristol-Myers Squibb Company (NYSE: BMY) is included among the 11 The best affordable dividend shares to buy now.
Bristol-Myers Squibb Company (NYSE: BMY) is an American pharmaceutical giant that operates in multiple countries and is based in New Jersey. In the second quarter, the company’s growth portfolio registered two -digit sales, and at least seven products recorded an increase of more than 20% in sales. Among them, Breyanzi cancer cell therapy has more to double its sales in the period.
In the rooms ahead, investors can expect to increase Cobenfy sales. This new schizophrenia treatment obtained the approval of the Food and Drug Administration last September, and sales are expected to reach $ 2.6 billion by 2030.
This year, the great pharmaceutical company expects profits to be terrified in a range between $ 6.35 and $ 6.65 per share. That is more than more than you need to fulfill a dividend commitment currently established at $ 2.48 annualized per share. With a strong line of new products to compensate for losses due to the next patent expirations, its high performance dividend could continue to grow for at least another decade.
Bristol-Myers Squibb Company (NYSE: BMY) has increased its dividends for 16 consecutive years. The company pays a dividend per share of $ 0.62 each quarter and has a dividend yield of 5.39%, as of October 2.
While we recognize BMY’s potential as an investment, we believe that certain AI actions offer greater upward potential and have less downward risk. If you are looking for an extremely undervalued action that also benefits significantly from the Trump era tariffs and the wave trend, see our free report on the The best short -term AI actions.
Read below: 12 Best Reit Dividend Shares to Buy Now and 10 higher shares that pay dividends to buy in the S&P 500.
Disclosure: None.
(Tagstotranslate) Bristol-Myers Squibb Company (T) Food and Drug Administration (T) Schizophrenia Treatment (T) Increased sales